Elunonavir

Elunonavir (GS-1156) is a HIV protease inhibitor with a high barrier to resistance and excellent metabolic stability. Elunonavir is able to overcome rapid CYP-mediated metabolism, resulting in a significantly prolonged half-life and the potential to reduce dosing frequency without the need for pharmacokinetic enhancers[1].

Product Specifications

CAS Number

[2242428-57-3]

UNSPSC

12352005

Target

HIV Protease

Type

Reference compound

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/elunonavir.html

Smiles

O=C(N[C@@H](CC1=CC=C(C#CC2=CN=C(N=C2)N3CC4CCC(C3)N4C5COC5)C=C1)[C@H](CN(CC(C(F)=C6)=C(F)C=C6C7=NN(C(F)F)C=C7)NC([C@@H](NC(OC)=O)C(C)(C(F)(F)F)C)=O)O)[C@@H](NC(OC)=O)C(C)(C(F)(F)F)C